Maxim L Filipenko (Maxim Filipenko, M L Filipenko)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 12

Top Venues

Biomolecules

Antibiotics (Basel, Switzerland)

Arkhiv patologii

International journal of molecular sciences

Institute of Chemical Biology and Fundamental Medicine SB RAS

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Institute of Chemical Biology and Fundamental Medicine SB RAS

Russia

Head of Lab

Publications

Maksim A Koryukov, Igor P Oscorbin, Lidiya M Novikova, Maria A Gordukova, Irina E Turina, Elena V Galeeva, Dmitry A Kudlay, Maxim L Filipenko
A Novel Multiplex LAMP Assay for the Detection of Respiratory Human Adenoviruses. International journal of molecular sciences 25 (13) (2024)
Maksim A Koryukov, Igor P Oscorbin, Lidiya M Novikova, Maria A Gordukova, Irina E Turina, Elena V Galeeva, Dmitry A Kudlay, Maxim L Filipenko
A Novel Multiplex LAMP Assay for the Detection of Respiratory Human Adenoviruses. International journal of molecular sciences 25 (13) (2024)
Ainur Akhmetova, Venera Bismilda, Lyailya Chingissova, Maxim L Filipenko, Ainur R Akilzhanova, Ulan Kozhamkulov
Prevalence of Beijing Central Asian/Russian Cluster 94-32 among Multidrug-Resistant M. tuberculosis in Kazakhstan. Antibiotics (Basel, Switzerland) 13 (1) (2023)
Igor P Oscorbin, Maxim L Filipenko
A Novel Thermostable and Processive Reverse Transcriptase from a Group II Intron of Anoxybacillus flavithermus . Biomolecules 14 (1) (2023)
E M Olyushina, L E Zavalishina, E Yu Alekseenok, N A Oskina, Yulia Yu Andreeva, O A Kuznetsova, Maxim L Filipenko, G A Frank
[Investigation of the mutational status of the FGFR3 gene in urothelial bladder carcinoma]. Arkhiv patologii 85 (2) (2023)
Igor P Oscorbin, Maxim L Filipenko
A Novel Thermostable and Processive Reverse Transcriptase from a Group II Intron of Anoxybacillus flavithermus . Biomolecules 14 (1) (2023)
Igor P Oscorbin, Maxim L Filipenko
A Novel Thermostable and Processive Reverse Transcriptase from a Group II Intron of Anoxybacillus flavithermus . Biomolecules 14 (1) (2023)
Ainur Akhmetova, Venera Bismilda, Lyailya Chingissova, Maxim L Filipenko, Ainur R Akilzhanova, Ulan Kozhamkulov
Prevalence of Beijing Central Asian/Russian Cluster 94-32 among Multidrug-Resistant M. tuberculosis in Kazakhstan. Antibiotics (Basel, Switzerland) 13 (1) (2023)
V E Rodionov, A M Avdalyan, Dmitriy Konovalov, N V Boriskin, I N Tyurin, Denis N Protsenko, O V Zayratyants, Maxim L Filipenko, Igor P Oscorbin, Maksim A Koryukov
[Features of the cell composition of inflammatory infiltrate in different phases of diffuse alveolar lung damage with COVID-19]. Arkhiv patologii 84 (3) (2022)
Anna Lipovka, Alexey Kharchenko, Andrey Dubovoy, Maxim L Filipenko, Vyacheslav Stupak, Alexander Mayorov, Vladislav V Fomenko, Pavel V Geydt, Daniil Parshin
The Effect of Adding Modified Chitosan on the Strength Properties of Bacterial Cellulose for Clinical Applications. Polymers 13 (12) (2021)
Irina Vladimirovna Galtseva, Maxim L Filipenko, Yulia O Davydova, A V Luchkin, N M Kapranov, Yu A Kondratieva, Sergey Subbotin, E A Khrapov, K A Nikiforova, Z T Fidarova, Tatiana V Gaponova, L P Mendeleyeva, E A Mikhailova, Elena N Parovichnikova, S M Kulikov
Comparison of polymerase chain reaction and flow cytometry for measuring telomere length of human leukocytes. Klinicheskaia laboratornaia diagnostika 66 (3) (2021)
Natalya Oskina, Igor Oscorbin, Evgeniy Khrapov, Ulyana Boyarskikh, Dmitriy Subbotin, Irina Demidova, Evgeny Imyanitov, Maxim L Filipenko
Highly Sensitive and Reliable Detection of EGFR Exon 19 Deletions by Droplet Digital Polymerase Chain Reaction. Molecular diagnosis & therapy 21 (5) (2018)

Maxim L Filipenko.css-eqlu8i{font-size:small;padding-left:4px;} (Maxim Filipenko, M L Filipenko)

Publication Activity (10 Years)

Top Topics

Top Venues

Maxim L Filipenko (Maxim Filipenko, M L Filipenko)